156.98
0.30 (0.19%)
前收盘价格 | 156.68 |
收盘价格 | 156.58 |
成交量 | 649,016 |
平均成交量 (3个月) | 890,756 |
市值 | 7,725,644,800 |
预期市盈率 (P/E Forward) | 16.45 |
价格/销量 (P/S) | 1.98 |
股市价格/股市净资产 (P/B) | 2.30 |
52周波幅 | |
利润日期 | 5 Nov 2025 |
营业毛利率 | -0.49% |
营业利益率 (TTM) | 13.62% |
稀释每股收益 (EPS TTM) | -0.600 |
季度收入增长率 (YOY) | -2.70% |
季度盈利增长率 (YOY) | -62.20% |
总债务/股东权益 (D/E MRQ) | 92.21% |
流动比率 (MRQ) | 1.43 |
营业现金流 (OCF TTM) | 776.39 M |
杠杆自由现金流 (LFCF TTM) | 625.62 M |
资产报酬率 (ROA TTM) | 4.26% |
股东权益报酬率 (ROE TTM) | -0.67% |
市场趋势
短期 | 中期 | ||
行业 | Diagnostics & Research (US) | 混合的 | 混合的 |
Diagnostics & Research (全球的) | 混合的 | 混合的 | |
股票 | Charles River Laboratories Inte | 看涨 | 看跌 |
AIStockmoo 评分
分析师共识 | 3.0 |
内部交易活动 | -3.0 |
价格波动 | -2.0 |
技术平均移动指标 | 3.5 |
技术振荡指标 | -2.5 |
平均 | -0.20 |
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company’s research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services. |
|
部门 | Healthcare |
行业 | Diagnostics & Research |
投资方式 | Small Value |
内部持股比例 | 1.01% |
机构持股比例 | 111.10% |
所有权
姓名 | 日期 | 持有股份 |
---|---|---|
Allspring Global Investments Holdings, Llc | 30 Jun 2025 | 2,291,126 |
Nomura Holdings Inc | 30 Jun 2025 | 1,569,269 |
Ariel Investments, Llc | 30 Jun 2025 | 1,415,348 |
Invesco Ltd. | 30 Jun 2025 | 1,237,143 |
Harris Associates L P | 30 Jun 2025 | 1,162,935 |
Mackenzie Financial Corp | 30 Jun 2025 | 1,002,049 |
Earnest Partners Llc | 30 Jun 2025 | 998,257 |
52周波幅 | ||
目标价格波幅 | ||
高 | 200.00 (Citigroup, 27.41%) | 购买 |
中 | 182.00 (15.94%) | |
低 | 160.00 (JP Morgan, 1.92%) | 保留 |
平均值 | 179.40 (14.28%) | |
总计 | 3 购买, 2 保留 | |
平均价格@调整类型 | 148.80 |
公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
---|---|---|---|---|
Evercore ISI Group | 08 Aug 2025 | 190.00 (21.03%) | 购买 | 148.74 |
09 Jul 2025 | 180.00 (14.66%) | 购买 | 158.97 | |
Barclays | 07 Aug 2025 | 165.00 (5.11%) | 保留 | 149.78 |
JP Morgan | 07 Aug 2025 | 160.00 (1.92%) | 保留 | 149.78 |
Citigroup | 09 Jul 2025 | 200.00 (27.40%) | 购买 | 158.97 |
Redburn Atlantic | 23 May 2025 | 182.00 (15.94%) | 购买 | 136.73 |
名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
---|---|---|---|---|
LAPLUME JOSEPH W | - | 149.78 | -400 | -59,912 |
累积净数量 | -400 | |||
累积净值 ($) | -59,912 | |||
累积平均购买 ($) | - | |||
累积平均卖出 ($) | 149.78 |
名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
---|---|---|---|---|---|---|
LAPLUME JOSEPH W | 职员 | 07 Aug 2025 | 卖 (-) | 400 | 149.78 | 59,912 |
5年平均股息收益率 | 0.00% |
除息日 | 公告日期 | 支付日期 | 详情 |
---|---|---|---|
28 Nov 1996 | 20 Nov 1996 | 12 Dec 1996 | 0.1 现金 |
29 Oct 1996 | 23 Oct 1996 | 12 Dec 1996 | 0.1 现金 |
26 Sep 1996 | 19 Sep 1996 | 14 Nov 1996 | 0.1 现金 |
28 Aug 1996 | 21 Aug 1996 | 14 Nov 1996 | 0.1 现金 |
29 Jul 1996 | 23 Jul 1996 | 14 Nov 1996 | 0.1 现金 |
26 Jun 1996 | 20 Jun 1996 | 14 Aug 1996 | 0.1 现金 |
29 May 1996 | 20 May 1996 | 14 Aug 1996 | 0.1 现金 |
26 Apr 1996 | 18 Apr 1996 | 14 Aug 1996 | 0.1 现金 |
27 Mar 1996 | 22 Mar 1996 | 15 May 1996 | 0.1 现金 |
27 Dec 1995 | 20 Dec 1995 | 14 Feb 1996 | 0.1 现金 |
28 Nov 1995 | 20 Nov 1995 | 14 Feb 1996 | 0.1 现金 |
27 Oct 1995 | 17 Oct 1995 | 14 Feb 1996 | 0.1 现金 |
27 Sep 1995 | 19 Sep 1995 | 14 Nov 1995 | 0.1 现金 |
29 Aug 1995 | 18 Aug 1995 | 14 Nov 1995 | 0.1 现金 |
27 Jul 1995 | 18 Jul 1995 | 14 Nov 1995 | 0.1 现金 |
28 Jun 1995 | 19 Jun 1995 | 14 Aug 1995 | 0.1 现金 |
24 May 1995 | 17 May 1995 | 14 Aug 1995 | 0.1 现金 |
24 Apr 1995 | 20 Apr 1995 | 14 Aug 1995 | 0.1 现金 |
显示更多 |
支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。
投资组合